ABL1 and acute lymphoblastic leukemia: Monitoring BCR-ABL1 transcripts for MRD by real-time quantitative reverse transcription polymerase chain reaction (RT-qPCR) is now an essential component in the management of Ph+ chronic myeloid leukemia and this approach may also be applied to Ph+ ALL patients as a means of assessing MRD and therefore therapeutic efficacy.